In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide information on skin structure, function, and immunology, then offer overviews of the therapeutic state of the art for both melanoma and non-melanoma skin cancers. Discussions focus on unique clinical challenges and biological breakthroughs which have come to light in recent studies of cutaneous malignancies.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Epidemiology and Screening for Melanoma - p. 889 9. Cutaneous Imaging Techniques - p. 907 10. Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution - p. 921 11. Nevi and Melanoma - p. 939 12. Advances in Adjuvant and Neoadjuvant Therapy for Melanoma - p. 953 13. Targeted Therapy Innovations for Melanoma - p. 973 14. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy - p. 997 15. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity - p. 1011 16. Melanoma Brain Metastasis: Biology and Therapeutic Advances - p. 1027 17. Advances in Vaccines for Melanoma - p. 1045 18. Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application? - p. 1061 19. High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances - p. 1071 20. Cutaneous T-cell Lymphoma - p. 1087 21. Cutaneous B-Cell Lymphomas - p. 1111 22. Merkel Cell Carcinoma - p. 1133
In this issue of Hematology/Oncology Clinics, guest editor Dr. David E. Fisher brings his considerable expertise to the topic of Cutaneous Oncology. Top experts first provide information on skin structure, function, and immunology, then offer overviews of the therapeutic state of the art for both melanoma and non-melanoma skin cancers. Discussions focus on unique clinical challenges and biological breakthroughs which have come to light in recent studies of cutaneous malignancies.
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xii 7. Preface - p. xiii 8. Epidemiology and Screening for Melanoma - p. 889 9. Cutaneous Imaging Techniques - p. 907 10. Unraveling the Functional Heterogeneity of Human Skin at Single-Cell Resolution - p. 921 11. Nevi and Melanoma - p. 939 12. Advances in Adjuvant and Neoadjuvant Therapy for Melanoma - p. 953 13. Targeted Therapy Innovations for Melanoma - p. 973 14. Progress in Immune Checkpoint Inhibitor for Melanoma Therapy - p. 997 15. Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity - p. 1011 16. Melanoma Brain Metastasis: Biology and Therapeutic Advances - p. 1027 17. Advances in Vaccines for Melanoma - p. 1045 18. Microbiome and Immunotherapy for Melanoma: Are We Ready for Clinical Application? - p. 1061 19. High-Risk Non-Melanoma Skin Cancers: Biological and Therapeutic Advances - p. 1071 20. Cutaneous T-cell Lymphoma - p. 1087 21. Cutaneous B-Cell Lymphomas - p. 1111 22. Merkel Cell Carcinoma - p. 1133
